Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2
- PMID: 15883123
- PMCID: PMC1755260
- DOI: 10.1136/ard.2004.028191
Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2
Abstract
Objective: To determine whether oncostatin M (OSM) + tumour necrosis factor alpha (TNFalpha) induces aggrecanase activity in chondrocyte membranes, to determine the effects of transforming growth factor beta1 (TGFbeta1), interleukin 4 (IL4), and tissue inhibitor of metalloproteinases (TIMPs) on this activity, and to determine whether this activity is due to a known ADAMTS aggrecanase.
Methods: Aggrecanase activity and ability of agents to prevent membrane associated aggrecanase activity were assessed by Western blotting. Expression of known aggrecanases was measured by real time polymerase chain reaction in bovine nasal and human articular chondrocytes.
Results: Chondrocyte membrane associated aggrecanase activity and increased mRNA expression of ADAMTS-1, -4, -5, and -9, but not ADAMTS-4 or -15, were enhanced after stimulation by OSM+TNFalpha in bovine chondrocytes. This activity was inhibited by TIMP-3. In human chondrocytes, OSM+TNFalpha also enhanced ADAMTS-1 and -4 expression, but not that of other ADAMTSs. TNFalpha alone induced ADAMTS-9 expression, whereas OSM addition caused suppression. Both TGFbeta1 and IL4 blocked membrane associated aggrecanase activity and decreased OSM+TNFalpha-induced expression of ADAMTS-9 in bovine and human chondrocytes. IL4 down regulated ADAMTS-4 mRNA, whereas TGFbeta1 increased this expression in both bovine and human chondrocytes.
Conclusions: OSM+TNFalpha up regulates membrane associated aggrecanase activity and several ADAMTS aggrecanase mRNAs in chondrocytes. The chondroprotective effects of IL4 and TIMP-3 suggest that they may have therapeutic benefit for aggrecanolysis, whereas the differential inhibitory effects of TGFbeta1 may limit its therapeutic potential. Induced membrane associated aggrecanase activity is distinct from known soluble ADAMTS aggrecanases and merits further investigation.
Figures
Similar articles
-
Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.Arthritis Rheum. 2008 Nov;58(11):3498-509. doi: 10.1002/art.24025. Arthritis Rheum. 2008. PMID: 18975307
-
Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular chondrocytes.J Cell Biochem. 2008 Feb 1;103(2):588-97. doi: 10.1002/jcb.21434. J Cell Biochem. 2008. PMID: 17546624
-
Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.Biochim Biophys Acta. 2007 Mar;1773(3):309-20. doi: 10.1016/j.bbamcr.2006.11.018. Epub 2006 Dec 15. Biochim Biophys Acta. 2007. PMID: 17208315
-
Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis.Curr Pharm Biotechnol. 2008 Feb;9(1):16-23. doi: 10.2174/138920108783497622. Curr Pharm Biotechnol. 2008. PMID: 18289053 Review.
-
Aggrecanase-mediated cartilage degradation.Curr Opin Pharmacol. 2002 Jun;2(3):322-9. doi: 10.1016/s1471-4892(02)00148-0. Curr Opin Pharmacol. 2002. PMID: 12020478 Review.
Cited by
-
The Effect of Mesenchymal Stem Cell Wharton's Jelly on Matrix Metalloproteinase-1 and Interleukin-4 Levels in Osteoarthritis Rat Model.Open Access Maced J Med Sci. 2019 Feb 27;7(4):529-535. doi: 10.3889/oamjms.2019.152. eCollection 2019 Feb 28. Open Access Maced J Med Sci. 2019. PMID: 30894907 Free PMC article.
-
Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M.BMC Complement Altern Med. 2016 Jul 11;16:205. doi: 10.1186/s12906-016-1183-0. BMC Complement Altern Med. 2016. PMID: 27400672 Free PMC article.
-
Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.Ann Rheum Dis. 2009 Jun;68(6):1051-8. doi: 10.1136/ard.2007.086884. Epub 2008 Jul 28. Ann Rheum Dis. 2009. PMID: 18662930 Free PMC article.
-
Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture.J Tissue Eng Regen Med. 2010 Dec;4(8):611-8. doi: 10.1002/term.275. J Tissue Eng Regen Med. 2010. PMID: 20568084 Free PMC article.
-
Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.Exp Ther Med. 2015 May;9(5):1979-1983. doi: 10.3892/etm.2015.2310. Epub 2015 Feb 24. Exp Ther Med. 2015. PMID: 26136925 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous